No Cover Image

Journal article 787 views

The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

Wu Li-Tzy, Andy C Parrott, Christopher L Ringwalt, Chongming Yang, Dan G Blazer, Andrew Parrott

American Journal on Addictions, Volume: 18, Issue: 6, Pages: 452 - 461

Swansea University Author: Andrew Parrott

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.3109/10550490903206049

Abstract

This study investigated the heterogeneity of ecstasy or MDMA (3,4-methylenedioxy-N-methylamphetamine) users. Data came from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Latent class analysis (LCA) and multinomial logistic regression procedures were used to...

Full description

Published in: American Journal on Addictions
ISSN: 1055-0496 1521-0391
Published: 2009
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa9307
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2013-07-23T12:02:04Z
last_indexed 2018-02-09T04:38:11Z
id cronfa9307
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2014-03-13T11:41:52.2787043</datestamp><bib-version>v2</bib-version><id>9307</id><entry>2012-03-19</entry><title>The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions</title><swanseaauthors><author><sid>3c706e6f0763eeaf11b0cc8b37d6757f</sid><ORCID/><firstname>Andrew</firstname><surname>Parrott</surname><name>Andrew Parrott</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2012-03-19</date><deptcode>HPS</deptcode><abstract>This study investigated the heterogeneity of ecstasy or MDMA (3,4-methylenedioxy-N-methylamphetamine) users. Data came from the 2001&#x2013;2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Latent class analysis (LCA) and multinomial logistic regression procedures were used to identify subtypes of ecstasy users. Approximately 1.6% (n=562) of adult participants (N=43,093) reported lifetime ecstasy/MDMA use. LCA identified three subtypes of ecstasy/MDMA users. Class 1 exhibited pervasive use of most drug classes (ecstasy&#x2013;polydrug users, 37%). Class 2 reported a high rate of use of marijuana and cocaine and a moderate use of amphetamines (ecstasy&#x2013;marijuana&#x2013;stimulant users, 29%). Class 3 was characterized by a high rate of use of marijuana and a low use of primarily prescription-type drugs (ecstasy&#x2013; marijuana users, 34%). Subtypes were distinguished by family income, history of substance abuse treatment, and familial substance abuse. Class 1 exhibited the highest prevalence of disorders related to the use of marijuana (77%), tobacco (66%), amphetamines (36%), opioids (35%), sedatives (31%), and tranquilizers (30%). The recent resurgence in ecstasy use among adults underscores the need to monitor trends in its use.</abstract><type>Journal Article</type><journal>American Journal on Addictions</journal><volume>18</volume><journalNumber>6</journalNumber><paginationStart>452</paginationStart><paginationEnd>461</paginationEnd><publisher/><issnPrint>1055-0496</issnPrint><issnElectronic>1521-0391</issnElectronic><keywords/><publishedDay>30</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2009</publishedYear><publishedDate>2009-11-30</publishedDate><doi>10.3109/10550490903206049</doi><url/><notes/><college>COLLEGE NANME</college><department>Psychology</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HPS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2014-03-13T11:41:52.2787043</lastEdited><Created>2012-03-19T09:05:03.5677030</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Psychology</level></path><authors><author><firstname>Wu</firstname><surname>Li-Tzy</surname><order>1</order></author><author><firstname>Andy C</firstname><surname>Parrott</surname><order>2</order></author><author><firstname>Christopher L</firstname><surname>Ringwalt</surname><order>3</order></author><author><firstname>Chongming</firstname><surname>Yang</surname><order>4</order></author><author><firstname>Dan G</firstname><surname>Blazer</surname><order>5</order></author><author><firstname>Andrew</firstname><surname>Parrott</surname><orcid/><order>6</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2014-03-13T11:41:52.2787043 v2 9307 2012-03-19 The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions 3c706e6f0763eeaf11b0cc8b37d6757f Andrew Parrott Andrew Parrott true false 2012-03-19 HPS This study investigated the heterogeneity of ecstasy or MDMA (3,4-methylenedioxy-N-methylamphetamine) users. Data came from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Latent class analysis (LCA) and multinomial logistic regression procedures were used to identify subtypes of ecstasy users. Approximately 1.6% (n=562) of adult participants (N=43,093) reported lifetime ecstasy/MDMA use. LCA identified three subtypes of ecstasy/MDMA users. Class 1 exhibited pervasive use of most drug classes (ecstasy–polydrug users, 37%). Class 2 reported a high rate of use of marijuana and cocaine and a moderate use of amphetamines (ecstasy–marijuana–stimulant users, 29%). Class 3 was characterized by a high rate of use of marijuana and a low use of primarily prescription-type drugs (ecstasy– marijuana users, 34%). Subtypes were distinguished by family income, history of substance abuse treatment, and familial substance abuse. Class 1 exhibited the highest prevalence of disorders related to the use of marijuana (77%), tobacco (66%), amphetamines (36%), opioids (35%), sedatives (31%), and tranquilizers (30%). The recent resurgence in ecstasy use among adults underscores the need to monitor trends in its use. Journal Article American Journal on Addictions 18 6 452 461 1055-0496 1521-0391 30 11 2009 2009-11-30 10.3109/10550490903206049 COLLEGE NANME Psychology COLLEGE CODE HPS Swansea University 2014-03-13T11:41:52.2787043 2012-03-19T09:05:03.5677030 Faculty of Medicine, Health and Life Sciences School of Psychology Wu Li-Tzy 1 Andy C Parrott 2 Christopher L Ringwalt 3 Chongming Yang 4 Dan G Blazer 5 Andrew Parrott 6
title The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
spellingShingle The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
Andrew Parrott
title_short The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
title_full The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
title_fullStr The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
title_full_unstemmed The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
title_sort The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
author_id_str_mv 3c706e6f0763eeaf11b0cc8b37d6757f
author_id_fullname_str_mv 3c706e6f0763eeaf11b0cc8b37d6757f_***_Andrew Parrott
author Andrew Parrott
author2 Wu Li-Tzy
Andy C Parrott
Christopher L Ringwalt
Chongming Yang
Dan G Blazer
Andrew Parrott
format Journal article
container_title American Journal on Addictions
container_volume 18
container_issue 6
container_start_page 452
publishDate 2009
institution Swansea University
issn 1055-0496
1521-0391
doi_str_mv 10.3109/10550490903206049
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str School of Psychology{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Psychology
document_store_str 0
active_str 0
description This study investigated the heterogeneity of ecstasy or MDMA (3,4-methylenedioxy-N-methylamphetamine) users. Data came from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Latent class analysis (LCA) and multinomial logistic regression procedures were used to identify subtypes of ecstasy users. Approximately 1.6% (n=562) of adult participants (N=43,093) reported lifetime ecstasy/MDMA use. LCA identified three subtypes of ecstasy/MDMA users. Class 1 exhibited pervasive use of most drug classes (ecstasy–polydrug users, 37%). Class 2 reported a high rate of use of marijuana and cocaine and a moderate use of amphetamines (ecstasy–marijuana–stimulant users, 29%). Class 3 was characterized by a high rate of use of marijuana and a low use of primarily prescription-type drugs (ecstasy– marijuana users, 34%). Subtypes were distinguished by family income, history of substance abuse treatment, and familial substance abuse. Class 1 exhibited the highest prevalence of disorders related to the use of marijuana (77%), tobacco (66%), amphetamines (36%), opioids (35%), sedatives (31%), and tranquilizers (30%). The recent resurgence in ecstasy use among adults underscores the need to monitor trends in its use.
published_date 2009-11-30T03:11:14Z
_version_ 1763749998579679232
score 11.012924

Similar Items